Skip to main content
Catriona Jamieson, MD, Oncology, La Jolla, CA, UC San Diego Medical Center - Hillcrest

CatrionaHJamiesonMD

Oncology La Jolla, CA

Associate Professor, Medicine, UCSD School of Medicine

Dr. Jamieson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Jamieson's full profile

Already have an account?

Education & Training

  • Stanford Health Care
    Stanford Health CareFellowship, Blood & Bone Marrow Transplant, 1999 - 2002
  • University of British Columbia
    University of British ColumbiaClass of 1995

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1999 - 2024
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Top Doctors:San Diego Area Castle Connolly, 2013
  • Top Doctors:Southern California Castle Connolly, 2012
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Cirmtuzumab, a ROR1 Targeted Mab, Reverses Cancer Stemness, and Its Combination with Ibrutinib Is Safe and Effective: Planned Analysis of the Cirll Phase 1/2 Trial for...
    Catriona Jamieson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • A 14q32.31 Genomic-Imprinted DLK1-DIO3 microrna promotes Leukemogenesis By Inducing Stem Cell Quiescence and Inhibiting NK Cell Anti-Cancer Immunity
    Catriona Jamieson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Cirmtuzumab, a ROR1 Targeted Mab, Reverses Cancer Stemness, and Its Combination with Ibrutinib Is Safe and Effective: Planned Analysis of the Cirll Phase 1/2 Trial for...
    Catriona Jamieson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Inflammatory Cytokine Responsive Enzymatic Mutagenesis Fuels Myeloproliferative Neoplasm Pre-Leukemia Stem Cell Evolution 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • RNA Modifications in Hematologic Malignancies 
    60th American Society of Hematology Annual Meeting - 12/2/2018
  • RNA Modifications in Hematology 
    60th American Society of Hematology Annual Meeting - 12/1/2018
  • Join now to see all

Press Mentions

  • Targeting Therapy-Resistant Pediatric Acute Myeloid Leukemia
    Targeting Therapy-Resistant Pediatric Acute Myeloid LeukemiaMarch 8th, 2023
  • UC San Diego’s Astrobiotechnology Hub to Drive Drug Discovery in Space
    UC San Diego’s Astrobiotechnology Hub to Drive Drug Discovery in SpaceFebruary 28th, 2023
  • Small Molecule Drug Reverses ADAR1-Induced Cancer Stem Cell Cloning Capacity
    Small Molecule Drug Reverses ADAR1-Induced Cancer Stem Cell Cloning CapacityFebruary 16th, 2023
  • Join now to see all

Hospital Affiliations